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Letter to the Editor
Gluthathion S-transferase M1 and T1 
polymorpisms in a group of Romanian 
glaucoma patients
DOI: 10.1515/rrlm-2015-0048
To the Editor: 
Glaucoma is the second leading cause of 
blindness in the world, after cataract, accord-
ing to the World Health Organization (WHO). 
According to some studies (1), the number of 
glaucoma patients worldwide is expected to in-
crease up to 111.8 million by 2040, with 74% 
of them suffering from primary open angle glau-
coma (POAG), the most common type of glau-
coma. Although, the exact number of glaucoma 
patients in Romania is not known, ophthalmolo-
gists describe an increasing prevalence of POAG 
among patients which often present in very late 
stages of the disease.
Although, high intraocular pressure (IOP) 
is recognized as being the main risk factor, the 
pathophysiology of POAG is considered multi-
factorial and multiple theories have been issued: 
mechanical damage due to high IOP, vascular 
dysregulation, altered intracranial pressure dy-
namics, glutamate excitotoxicity, nitric oxide 
dysregulation, astrocite reactivation, extracel-
lular matrix remodelling, mutations in specific 
genes, changes in the mitochondrial genome, 
blood-retinal barrier breakdown and secondary 
low-grade inflammation, toxic effects and oxida-
tive damage caused by reactive oxygen species 
(ROS) (3,10).
Multiple in vivo and in vitro studies provide 
evidence for the involvement of reactive oxy-
gen species (ROS) in POAG pathogenesis. An 
impairment of the eye’s proficient antioxidant 
defence mechanisms, like reduced glutathione 
(GSH), seems to favour the progressive accumu-
lation of oxidative damage which alters aqueous 
humour drainage pathways, increases IOP levels 
and triggers the ‘pathogenic cascade’ of POAG, 
ultimately leading to death of RGC through 
apoptosis. Glutathione-S-transferases (GSTs) are 
a family of phase II drug metabolising enzymes 
mostly known for their ability to catalyse the 
conjugation of reduced glutathione with a wide 
variety of electrophiles, including carcinogens 
and oxidative stress products. Null mutations of 
gluthathione S-transferase M1 (GSTM1) and T1 
(GSTT1) are mainly responsible for the impair-
ment or absence of GST enzymatic activity and 
have been involved in the pathogenesis of multi-
ple disorders, including glaucoma (3).
GSTM1 and GSTT1 polymorphisms have 
been highly investigated as possible risk fac-
tors for POAG in various populations across the 
globe with inconsistent results (4-9). As none 
of these included a Romanian population, we 
thought it necessary to investigate the distribu-
tion of GSTM1 and GSTT1 polymorphisms in 
Romanian patients with POAG and in controls, 
to explore the possible association between 
GSTM1 and GSTT1 null genotypes and POAG 
in these patients. We then evaluated their impact 
on glaucoma subgroups according to family his-
tory, extra-ocular risk factors, surgical treatment 
and severity.
After recruiting 157 patients with POAG and 
137 POAG glaucoma free patients or healthy 
controls who had given their informed consent, 
from the Ophthalmology Department of Cluj 
Emergency County Hospital, we conducted a 
cross-sectional, randomized case-control study. 
The tenets of the declaration of Helsinki were 
followed and the protocols for human experi-
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mentation and genetic testing were approved 
by the Ethical Commission of ‘Iuliu Haţieganu’ 
University of General Medicine and Pharmacy. 
All subjects recruited underwent a complete 
ophthalmological examination. POAG patients 
had to meet at least two of the following three 
criteria: (a) IOP above 21mmHg; (b) patholog-
ical cupping of the optic disc; (C) a glaucoma 
hemifield test (GHT) outside normal limits with 
consistent visual field defects at the same loca-
tion on at two consecutive visits and to have an 
open anterior chamber angle, at least grade III 
Schäfer.
Venous blood samples were obtained from 
all participants and DNA extraction was per-
formed using Wizard Genomic DNA Purifica-
tion Kit (Promega Madison, USA).  A multiplex 
polymerase chain reaction protocol (adapted af-
ter Bid HK et al. (10)) was used for GSTM1 and 
GSTT1 genes genotyping which easily identifies 
the GSTT1 and GSTM1 homozygous null gen-
otypes but, cannot distinguish between GSTM1 
and GSTT1 homozygous and heterozygous pos-
itive genotypes. 
For statistical analysis we used R software 
environment for statistics computing and graph-
ics version 3.2.1 (rms functions package). Bi-
variate analysis were carried out using t test, 
Chi-square or Fisher exact tests. Ordinal, mul-
tinomial, and binary logistic regression analyses 
were also conducted. We used odds ratio (OR) 
and 95% associated confidence interval to high-
light the size of tested associations. The level of 
significance in the multivariable logistic models 
and all two-sided tests was α=0.05. Statistical 
significance was given by an estimated signifi-
cance level, p<0.05.
The two groups were comparable, as no sig-
nificant differences were found with respect to 
age (student test for independent groups with 
unequal variances, p>0.05) and sex (chi-square 
test, statistics χ2=0.50, df=1, p=0.54).
In this study we found no evidence of an 
association between GSTM1null or GSTT1null 
genotypes and POAG (GSTM1 p=0.335, 
GSTT1 p=0.483). However, GSTM1null gen-
otype showed a borderline association with the 
risk of POAG among women (p=0.055, crude 
OR: 0.529 CI: 0.280-1.002), but not among men 
(p=0.414, crude OR: 1.79, CI: 0.596-5.38). Larg-
er studies might provide statistically significant 
results and confirm a higher risk of developing 
POAG among women presenting GSTM1 null 
genotype. This could be due to genetic and hor-
monal differences. Similar but consistent results 
were found among women presenting lung can-
cer, where altered DNA repair mechanisms and 
hyperestrogenism are incriminated for the differ-
ence in disease susceptibility between women 
and men who smoke. 
Our results are in agreement with the ones 
reported by Jansson et al who found no associa-
tion between GSTM1 null genotypes and POAG 
in a Swedish population (5,6). Similar results 
were also communicated for GSTM1 in a Bra-
zilian, Mexican (4) and Iranian (5) populations 
and for GSTT1 in an Estonian, Turkish, Mex-
ican, Brazilian  and Iranian population (5,6). 
Moreover, recent meta-analyses (7-9) found no 
significant association between GSTM1 null and 
GSTT1 genotypes and POAG in Caucasians. 
Only when analysis was stratified by ethnicity, 
a positive association was observed for GSTM1 
null genotype in East Asians (9).  
In contrast to our results, several studies have 
reported an increased risk of POAG in carriers 
of the GSTM1 null genotype in different popu-
lations (5-9). Only one study was able to docu-
ment the association between GSTT1null geno-
type and glaucoma in a Turkish population. The 
previously mentioned meta-analyses reported a 
significantly increased risk of POAG in carriers 
of the double null genotype. We found no study 
to assess sex influence on GSTM1 and GSTT1 
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null genotypes distribution among patients and 
controls. Many factors might account for the dif-
ference in results among similar studies, includ-
ing different genetic, ethnic and environmental 
background and disparities among study design 
and methodology.
In order to asses a possible association be-
tween GST profiles and POAG, we examined 
the risk of glaucoma associated with combina-
tions of genotypes. The reference group consist-
ed of individuals with both low risk genotypes 
GSTM1 present/GSTT1 present. We found no 
statistically significant difference among the ex-
amined combinations even when stratified by 
sex.
We investigated a possible role of previous 
family history of glaucoma or personal histo-
ry of extra-ocular conditions predisposing to 
POAG in determining genotype frequencies in 
the patient group, but found no evidence: per-
sonal history of extraocular conditions predis-
posing to POAG and GSTM1: Chi-square test, 
statistics χ2=2.441 p=0.137 OR=0.37, 95% CI: 
0.10-1.33; respectively GSTT1: Chi-square test, 
statistics χ2 =2.285 p=0.152, OR=1.9, 95% CI: 
0.82-4.40; for family history of glaucoma and 
GSTM1 χ2=0.123, p=0.802, OR=1.20, CI=0.42-
3.47, GSTT1 χ2=0.291, p=0.674  OR=1.256, 
95% CI: 0.54-2.88 (data not shown).
No statistically significant differences were 
found between patients who had or had not re-
quired surgical treatment for POAG with re-
spect to GSTM1 null genotype: Chi-square test, 
p=0.202 OR=2.28, 95% CI: 0.77-6.72,  and 
GSTT1 null genotype: Chi-square test, χ2=1.045, 
p=0.441, OR=0.58, 95% CI: 0.21-1.63) (data not 
shown).
As a declining mean deviation (MD) value 
on the visual field is characteristic for POAG 
progression, its values can help classify POAG 
into stages according to MD severity scale in 
mild (MD<-6), moderate (-12>MD≥-6) and ad-
vanced (MD≥-12) glaucoma. When evaluating 
factors influencing glaucoma severity according 
to MD staging scale, by ordinal logistic regres-
sion, we found that GSTM1 null genotype carri-
ers had a higher risk of developing a moderate or 
advanced disease as compared to patients with 
the wild type genotype (p=0.002, OR=3.362, 
95% CI: 1.45-7.77) (data not shown)). More-
over, when we examined GSTM1-GSTT1 com-
binations, patient carriers of the double null gen-
otype had a two-fold increased risk of moderate 
or severe glaucoma (p=0.003, OR=2.14, 95% 
CI: 0.70-6.49) (data not shown).
When multiple factors were evaluated as 
possible predictors of  moderate and advanced 
glaucoma by multinomial logistic regression, 
moderate glaucoma was greatly influenced by 
GSTM1null genotype (p=0.002, OR:9.17, 95% 
CI: 2.23-37.61), whereas advanced glaucoma 
was more frequent in patients dealing with glau-
coma for more than 10 years (p=0.02, OR:2.37, 
95% CI:1.17-4.78) and in GSTM1 null genotype 
carriers although we found only a trend to sta-
tistical significance (p=0.10, OR=2.48, CI=0.84-
7.3)(Table I). This might be due to the small sam-
ple size in glaucoma severity subgroups. Larger 
studies might confirm the association and reach 
valuable statistical parameters. We found no oth-
er study to investigate the impact of GSTM1 and 
GSTT1 null polymorphisms on disease severity.
In conclusion, our study found no statisti-
cally significant association between GSTM1 or 
GSTT1null genotypes and POAG possibly due 
to the limited sample size. Our results suggest 
that the impairment of GSTM1 enzymatic activ-
ity may influence POAG progression. Restoring 
their proper function might slower the degen-
erating path of POAG and provide a potential 
therapeutic target for POAG. Further studies of 
greater amplitude need to be conducted in mul-
tiple populations in order to elucidate glaucoma 
pathogenesis and progression.
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Table I. The results of univariate and multivariate logistic regression for types of glaucoma
Moderate vs. Early glaucoma
Predictors p** Crude OR 95% CI 
GSTM1(null/present) 0.003 7.95 2.06-30.74
GSTT1(null/present) 0.324 0.52 0.14-1.92
Family history (present/absent) 0.891 1.12 0.22-5.62
Extraocular  risk factors (present/absent) 0.080 0.30 0.08-1.16
Duration of disease 0.583 0.55 0.06-4.75
The multivariable logistic model p** Adjusted OR 95% CI 
GSTM1(null/positive) 0.002 9.17 2.23-37.61
GSTT1(null/positive) 0.362 0.52 0.13-2.12
Disease duration (≥10 years/<10) 0.548 0.49 0.05-4.91
APP (present/absent) 0.078 0.26 0.06-1.16
Intercept of model 0.021 - -
 
Advanced vs. Early glaucoma
Predictors p** Crude OR 95% CI 
GSTM1(null/present) 0.063 2.65 0.95-7.39
GSTT1(null/present) 0.126 0.48 0.18-1.23
Family history (present/absent) 0.931 1.05 0.32-3.43
Extraocular  risk factors (present/absent) 0.411 1.90 0.41-8.79
Duration of disease 0.011 2.42 1.23-4.77
The multivariable logistic model p** Adjusted OR 95% CI 
GSTM1(null/positive) 0.10 2.48 0.84-7.3
GSTT1(null/positive) 0.110 0.44 0.16-1.20
Extraocular risk factors (≥10 years/<10) 0.02 2.37 1.17-4.78
Extraocular risk factors (present/absent) 0.553 1.61 0.33-7.73
Model intercept 0.002 - -
*estimated unstandardized regression coefficients; SE=standard error;CI=confidence interval
** Wald’s test adjusted p-value
1. “Iuliu Hatieganu” University of General 
Medicine and Pharmacy
2. “Iuliu Hatieganu” University of General 
Medicine and Pharmacy, Ophthalmology De-
partment
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Abbreviations
POAG- primary open angle glaucoma
RGC- retinal ganglion cells
GST Glutathione S Transferase
GSTM1 - Glutathione S Transferase M1
GSTM1- Glutathione S transferare T 1
PCR- polymerase chain reaction
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